Where MedTech professionals gain clarity and confidence to navigate complex decisions.
Let's Talk Risk! Podcast
Let’s Talk Risk! brings together MedTech leaders and practitioners for thoughtful conversations on the challenges that shape risk, quality, innovation, and leadership. With 150+ episodes and more than 30K downloads, it helps professionals gain the clarity and confidence to lead through complex decisions. naveenagarwalphd.substack.com
Be sure to visit the podcast's website and support the creator: naveenagarwalphd.substack.com
Author
Where MedTech professionals gain clarity and confidence to navigate complex decisions.
Category
Podcast website
Latest episode
Nov 12, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
LTR 64: Opportunities and challenges to leverage PCCP for speed to market 31.10.2024 29:31
Summary “PCCP is a great tool for your regulatory strategy but it is not for every company or for every change”. PCCP (Predetermined Change Control Plan) is a new regulatory scheme that allows device manufacturers to implement post-market changes without requiring pre-market submission to the FDA. In this episode, Yu Zhao explains how the PCCP tool offer… This is a public episode. If you'd like to...
LTR 71: Medical device cybersecurity now more critical than ever 18.10.2024 31:20
“It is not just about protecting your data. It is also about protecting safety of a medical device.” In this Let’s Talk Risk! conversation , Nidhi Gani highlights the important difference between data security and cybersecurity, especially for a life-saving medical device such as a pacemaker. As medical devices become more inter-connected, they are also increasingly vulnerable to cyberattacks. Man...
LTR 69: A quick update on the 4th edition of IEC 60601 04.10.2024 35:29
“Technology has changed, we need to move with the technology change.” In this Let’s Talk Risk! conversation , Leo Eisner shares a brief history of IEC 60601, the comprehensive global safety standard for active medical devices, and the work currently ongoing on the 4th edition. He is leading the group currently working on the user-interface aspects, which includes information provided by the manufa...
LTR 68: Tips for making customer-focused decisions 27.09.2024 33:08
“Before making a decision, we have to look at the issues end-to-end. We have to consider how our actions will impact the customer.” In this Let’s Talk Risk! conversation , Rajesh Kathuria emphasizes the need to consider the full impact of our actions on safety of customers and users and quality of performance. As an example, when working at the component level, we should consider the impact of any...
LTR 67: 3 pillars for defining your IVD risk management strategy 20.09.2024 38:09
“There are 3 pillars I consider essential to defining a strategy for IVD risk management. What is the system definition, who are the user groups, and what is the level of novelty?” In this Let’s Talk Risk! conversation , Claudia Campbell-Matland highlights the broad range of in-vitro diagnostic devices (IVD), which requires a strategic approach to their development and risk management. Claudia adv...
LTR 66: Understanding human factors aspect of augmented reality applications in medical devices 13.09.2024 33:59
“To be able to see a virtual image over the real world - that augmented reality is - is a mind blowing, very different experience.” In this Let’s Talk Risk! conversation , Phil Deming shares some of the unique human factors engineering challenges for an augmented reality (AR) technology for 3D visualization of human anatomy in real time during a medical procedure. Phil advises manufacturers to sta...
LTR 65: Demystifying risk-based approach vs. risk management 06.09.2024 35:15
“It’s too often confused with risk management itself. Part of the risk-based approach is just the mindset, the thinking about risk, and then deciding ‘so what should we do?’, the answer to which might be a formal risk management.” In this Let’s Talk Risk! conversation , Steve Gompertz clarifies a subtle difference between a risk-based approach and formal risk management according to standards such...
LTR 63: A lawyer's perspective on the QMSR transition 23.08.2024 35:51
“Don’t be comfortable saying, ‘Oh I follow the ISO (13485) to the letter’; it doesn’t matter. You have to comply with 21 CFR 820.” In this Let’s Talk Risk! conversation , Neil Di Spirito, helps us understand the full legal context behind the Quality Management System Regulation (QMSR), the amended version of 21 CFR 820 that will go into effect in February 2026. Although, the QMSR incorporates the...
LTR 62: Overcoming barriers to cross-functional communication and collaboration 16.08.2024 30:49
“There is a growing awareness that if you bring in Regulatory at the beginning of designing a product, you will end up with a more robust product. In this Let’s Talk Risk! conversation , Christine Zomorodian highlights some of the barriers that have traditionally hindered good communication and collaboration between QA/RA and Engineering functions in MedTech. However, she also points out that ther...
LTR 61: Treat human factors as a driver of customer satisfaction, not a check-the-box activity 09.08.2024 39:23
“There is a tendency for human factors to be very closely tied to regulatory requirements and nothing else, but human factors as a core discipline is about user-centered design.” In this Let’s Talk Risk! conversation , Korey Johnson highlights how the current practice of human factors engineering in the medical device industry is mainly driven by regulatory requirements, which often leads to a che...
LTR 60: Defining state of the art can be challenging; here are a few tips. 02.08.2024 31:07
“There is a very strong push (in the EU) to look at threshold values and acceptance criteria in the clinical evaluation, and these acceptance criteria for benefit risk have to be based on the state of the art.” State of the art (SoTA) is a very important topic in the medical device industry, because it is directly connected to risk acceptability and benefit-risk evaluation, which in turn, is direc...
LTR 59: FDA's pre-sub program and how it can accelerate medical device innovation 26.07.2024 32:13
“You can get a lot of valuable insights from the FDA on what your regulatory pathway is when it comes to risk, and how that impacts not only the risk of the product but how you set up your quality systems and what you need to implement in the long run. ” In this Let’s Talk Risk! conversation , Amit Guruprasad shares how small medical device manufacturers and startups can take advantage of the free...
LTR 58: Tips for clinicians transitioning into a medical safety role in MedTech 19.07.2024 41:23
“The reality is that, today, a lot of people are studying medicine to go into industry. But if your curriculum do not include areas like risk management, cross-functional collaboration, dFMEA and all of that, then transition for that position is going to be slower.” In this Let’s Talk Risk! conversation , Dr. Juan Daccach shares his personal journey of transitioning into a medical safety role in M...
LTR 57: It's time to focus on supply chain resiliency not just supplier management 12.07.2024 34:09
“Show me the indicators, show me the KPIs and I will show you the results.” Resiliency starts at the top. Misaligned incentives often lead to unintended and disastrous consequences. Recently, the Federal Aviation Administration (FAA) in the US grounded 171 Boeing 737-9 MAX planes following a mid-air incident where a cabin door blew open, exposing hundreds of passengers to a serious hazardous condi...
LTR 56: How to communicate effectively with senior management 05.07.2024 31:28
“As professionals in these areas, we are so versed in regulations that we get so deep into the woods with management that 30 seconds after you start speaking, they are gone! They can’t even think about it anymore.” Know your audience, prepare your topic and respect your listener. Victor Mencarelli shares these 3 tips for effective communication in this Let’s Talk Risk! conversation. Remember, effe...
LTR 54: Start your risk analysis by first defining the intended use 21.06.2024 33:18
“The first thing I do whenever I am starting design control or risk is that I make sure that the intended use and the indication of the device are as nailed down as they can be.” Yes, design control and risk management can be challenging, especially in a startup or a small medical device company. Generally, there is just one person, a “team of one”, responsible for setting up the entire quality sy...
LTR 53: Three big trends to watch in MedTech 07.06.2024 35:41
“The regulatory landscape is changing significantly and it is too hard to keep up.” That is why Jennifer Mascioli-Tudor advises risk practitioners to be “super proactive” in following these rapid changes, understand the impact, and take a leading role in preparing their organizations. In this Let’s Talk Risk! conversation, we focus on three big trends in MedTech - the shift from Quality System (QS...
LTR 52: The key to success as a risk practitioner in the medical device industry. 31.05.2024 34:20
“Risk management is inherent to all our roles, whether you are in Regulatory, Quality or R&D, but it is not something we spend a lot of time on”. Risk management in the medical device industry is often seen as a check-the-box activity for regulatory compliance. In this Let’s Talk Risk! conversation, Carolyn Blandford encourages us to not be satisfied with this status quo and help create a dedicate...
LTR 50: Humility is the key to startup success 17.05.2024 35:16
“The teams I see really successful are the ones that realize where their gaps lie and stive to reach out to mentors and advisors to fill those gaps”. Developing a medical device and bringing it successfully to the market is a huge challenge, especially for early stage startups. Even for large, established manufacturers, it takes a significant amount of time to launch a new device. In this Let’s Ta...
RM roundup #3: 10 noteworthy risk-related LinkedIn posts 10.05.2024 21:51
Listen to my reading of a recent LinkedIn article I published to cover 10 noteworthy risk-related posts recently published on LinkedIn. Listen to the recording and follow links below to read the original posts and continue the conversation. 🗞️A roundup of 10 noteworthy risk-related posts on LinkedIn! 1️⃣ Horst Simon advises risk practitioners to serve as advisors and facilitators instead of playin...
LTR 49: A clinician's view on AI/ML enabled medical devices 03.05.2024 34:41
“The eyes can only see what the mind understands.” The world of medical devices is complex. There are many regulations, standards and guidance documents to read and understand, and apply them correctly during design, development and clinical investigations for regulatory success. In this Let’s Talk Risk! conversation, Dr. Emanuel Tkach encourages us to keep the big picture in mind. Engineers and C...
LTR 48: Integrating purchasing controls across product lifecycle 26.04.2024 34:38
“Continuous lifecycle approach to risk management is still not broadly understood or applied in the industry”. In this Let’s Talk Risk! conversation, Kevin Posey highlights a gap in the industry practice of risk management, especially in the context of purchasing controls. Starting with the recent Boeing issue, where a cabin door in a 737 Max 9 blew open during flight, Kevin shares that there is o...
LTR 46: Tips to boost effectiveness of medical device post-market surveillance 12.04.2024 33:22
“Risk management is often seen as a check the box activity”. Taylor Dieringer reminds us in this Let’s Talk Risk! conversation that risk management should be an ongoing, continuous process within your quality management system, that monitors, evaluates and controls risk throughout the product lifecycle, and not just in the pre-market phase. The post-market surveillance process serves as a link bet...
LTR Weekly Digest #31 - 6th April, 2024 06.04.2024 2:55
Dear colleagues, hello! 👋 A special welcome to the 40 new members who have joined our Let’s Talk Risk! community in the first week of April! Feel free to browse past articles in the archive section of the Let’s Talk Risk! website , and check out recordings of recent LTR conversations in the podcast section. Here are links to articles published this week. Announcements Special offer - save 20% on...
LTR 45: A patient's perspective on CGMs 05.04.2024 31:23
“Diabetes is a terrible way to die.” This comment from David Sturgis in our Let’s Talk Risk! conversation really moved me. As engineers and QA/RA professionals, we mainly focus on building and launching safe and effective medical devices. We don’t always get to spend time with patients and doctors to understand their perspective. That is why it is insightful to hear from David about his experience...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.